These 3 Words From the FDA Ensure the Biogen Drama Is Far From Over

These 3 Words From the FDA Ensure the Biogen Drama Is Far From Over

Although the company's Alzheimer's drug got approval from the agency, that doesn't mean you should rush out and buy this risky stock.